Crohn’s Disease Pipeline Insights, FDA Approvals, Drugs, Companies Report | DelveInsight
The leading Crohn's Disease companies such as Janssen, RedHill Biopharma, Amgen, Pfizer, Hoffmann-La Roche, Gilead Sciences, Eli Lilly and Company, Celgene, AstraZeneca, Abbvie, Mesoblast, Alfasigma, ...
Medical News Today1d
FDA-approved nasal spray for severe depression can lead to remission
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
FDA approves standalone use of J&J’s ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...
Hosted on MSN11mon
Pfizer's (PFE) Ulcerative Colitis Pill Velsipity Gets EU Nod
The FDA had approved Velsipity (etrasimod) for UC in October 2023. Velsipity’s approval was based on data from two pivotal phase III studies, ELEVATE UC 52 and ELEVATE 12. These studies ...
pharmaphorum2y
Etrasimod data suggests Pfizer's $6.7bn gamble on Arena will pay off
but will be watched keenly to see how it stacks up with etrasimod's main rival, Bristol-Myers Squibb's S1P drug Zeposia (ozanimod), which was approved for ulcerative colitis last year and is also ...
pharmaphorum2d
Lilly to file mirikizumab in Crohn’s after FDA colitis snub
The positive result is a welcome boost for Lilly’s programme, coming after the FDA rejected approval of mirikizumab ... Pfizer’s S1P candidate etrasimod, which has been filed for that ...
Hosted on MSN1mon
New uses for existing drugs could help combat antimicrobial resistance
Notably, an etrasimod ... treatments. Drug repurposing has become an increasingly attractive strategy in antibiotic discovery, with researchers screening large libraries of approved and ...